FTX-backed PayUp agreed to merge with IG Acquisition while multiple corporates participated in Line Man Wongnai’s $265m series B round.

RxCelerate took part in Rivus Pharmaceuticals’ $132m series B round while Bank of America and Citi backed AccessFintech’s $60m series C.

Beauty treatments, medical procedures and personalisation are blending together, with China at the forefront of these key trends.

Brevan Howard Digital has led a $35m series B round for Messari while Robert Bosch Venture Capital participated in Tulu’s $25m series A.

Novo Holdings led a $75m series C round for Kate Farms while PayU and InfoEdge Ventures participated in DotPe’s $58m series B.

Alphabet led a $1bn round for its life sciences unit, PTT bets on insect startup and corporate-backed Propzy is set to shut down.

Pfizer Ventures has led a $102m series A for Capstan Therapeutics while Globis Capital Partners took part in an $85.4m round for Andpad.

Spinouts working on ketamine-based therapeutics, regenerative medicines for dogs and better sleep are among those that caught our eye this month.

Access Industries, Pfizer and SR One were among the investors in a $125m round for Nimbus Therapeutics while Aerwins agreed a reverse takeover.

Alphabet led a $1bn round for its Verily subsidiary while Kimco Realty and The Silverman Group were part of Gotham Greens’ $310m series E.